RHEB1 insufficiency in aged male mice is associated with stress-induced seizures
- PMID: 28891034
- PMCID: PMC5745219
- DOI: 10.1007/s11357-017-9997-3
RHEB1 insufficiency in aged male mice is associated with stress-induced seizures
Abstract
The mechanistic target of rapamycin (mTOR), a protein kinase, is a central regulator of mammalian metabolism and physiology. Protein mTOR complex 1 (mTORC1) functions as a major sensor for the nutrient, energy, and redox state of a cell and is activated by ras homolog enriched in brain (RHEB1), a GTP-binding protein. Increased activation of mTORC1 pathway has been associated with developmental abnormalities, certain form of epilepsy (tuberous sclerosis), and cancer. Clinically, those mTOR-related disorders are treated with the mTOR inhibitor rapamycin and its rapalogs. Because the effects of chronic interference with mTOR signaling in the aged brain are yet unknown, we used a genetic strategy to interfere with mTORC1 signaling selectively by introducing mutations of Rheb1 into the mouse. We created conventional knockout (Rheb1 +/- ) and gene trap (Rheb1 Δ/+ ) mutant mouse lines. Rheb1-insufficient mice with different combinations of mutant alleles were monitored over a time span of 2 years. The mice did not show any behavioral/neurological changes during the first 18 months of age. However, after aging (> 18 months of age), both the Rheb1 +/- and Rheb1 Δ /- hybrid males developed rare stress-induced seizures, whereas Rheb1 +/- and Rheb1 Δ /- females and Rheb1 Δ/+ and Rheb1 Δ/Δ mice of both genders did not show any abnormality. Our findings suggest that chronic intervention with mTORC1 signaling in the aged brain might be associated with major adverse events.
Keywords: Gene targeting; Mice; Rapamycin; Rheb1; mTOR inhibitor; mTORC1.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures




Similar articles
-
Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.J Hematol Oncol. 2016 Apr 12;9:36. doi: 10.1186/s13045-016-0264-3. J Hematol Oncol. 2016. PMID: 27071307 Free PMC article.
-
Rheb1 deletion in myeloid cells aggravates OVA-induced allergic inflammation in mice.Sci Rep. 2017 Feb 22;7:42655. doi: 10.1038/srep42655. Sci Rep. 2017. PMID: 28225024 Free PMC article.
-
Rheb1-mTORC1 maintains macrophage differentiation and phagocytosis in mice.Exp Cell Res. 2016 Jun 10;344(2):219-28. doi: 10.1016/j.yexcr.2016.04.017. Epub 2016 May 7. Exp Cell Res. 2016. PMID: 27163399
-
Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling.Int J Mol Sci. 2024 Jan 25;25(3):1489. doi: 10.3390/ijms25031489. Int J Mol Sci. 2024. PMID: 38338768 Free PMC article. Review.
-
Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.Pediatr Neurol. 2015 Mar;52(3):281-9. doi: 10.1016/j.pediatrneurol.2014.10.028. Epub 2014 Nov 20. Pediatr Neurol. 2015. PMID: 25591831 Review.
Cited by
-
A novel rapamycin analog is highly selective for mTORC1 in vivo.Nat Commun. 2019 Jul 19;10(1):3194. doi: 10.1038/s41467-019-11174-0. Nat Commun. 2019. PMID: 31324799 Free PMC article.
-
Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy.Front Neurol. 2022 Apr 28;13:833624. doi: 10.3389/fneur.2022.833624. eCollection 2022. Front Neurol. 2022. PMID: 35572927 Free PMC article. Review.
-
Lysosome: The metabolic signaling hub.Traffic. 2019 Jan;20(1):27-38. doi: 10.1111/tra.12617. Epub 2018 Nov 14. Traffic. 2019. PMID: 30306667 Free PMC article. Review.
-
Age-related alterations of articular cartilage in pituitary adenylate cyclase-activating polypeptide (PACAP) gene-deficient mice.Geroscience. 2019 Dec;41(6):775-793. doi: 10.1007/s11357-019-00097-9. Epub 2019 Oct 26. Geroscience. 2019. PMID: 31655957 Free PMC article.
-
Advances and challenges in geroscience research: An update.Physiol Int. 2018 Dec 1;105(4):298-308. doi: 10.1556/2060.105.2018.4.32. Physiol Int. 2018. PMID: 30587027 Free PMC article. Review.
References
-
- Blair J, Barry R, Moore DJ, Denniston AK (2017) A comprehensive review of mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis. Curr Pharm Des 23(20):3005-3014. doi:10.2174/1381612823666170111125550 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous